[Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication

X Qi1, X Li, M Liu

  • 1Department of Epidemiology, Tianjin Medical University, Tianjin 300070, China.

Abstract

Insights

Antisense phosphorothioate oligodeoxynucleotide (AODN) effectively inhibited Coxsackie Virus B3 (CVB3) replication in vitro. This specific AODN demonstrated dose-dependent antiviral activity against CVB3, highlighting its potential as a therapeutic agent.

Area of Science:

  • Virology
  • Molecular Biology
  • Antiviral Therapy

Background:

  • Coxsackie Virus B3 (CVB3) is a significant human pathogen.
  • Effective antiviral strategies against CVB3 are crucial for public health.
  • Antisense oligodeoxynucleotides (AODN) show promise as targeted antiviral agents.

Purpose of the Study:

  • To evaluate the in vitro antiviral efficacy of a specific antisense phosphorothioate oligodeoxynucleotide (AODN).
  • To investigate the inhibitory effect of AODN on CVB3 replication in Vero cells.
  • To compare the antiviral activity of AODN with sense (SODN) and randomized (RODN) oligodeoxynucleotides.

Main Methods:

  • Synthesis of a 21-mer AODN targeting the 5' NCR of CVB3 RNA (nt 581-601).
  • Transfection of CVB3-infected Vero cells with varying concentrations of AODN, SODN, and RODN using lipofectamine.
  • Assessment of antiviral effects through inhibition of cytopathic effect (CPE), cell viability (MTT assay), viral antigen and RNA levels (ELISA, dot blotting), and viral titers (TCID50).

Main Results:

  • AODN significantly inhibited CVB3-induced CPE, viral antigen and RNA production, and viral titers in a dose-dependent manner.
  • Optimal inhibition was observed at 48 hours post-transfection with 10 µmol/L AODN, which also enhanced cell survival rates.
  • SODN exhibited a weaker inhibitory effect on CPE, while RODN showed no antiviral activity; AODN did not inhibit HSV-1 but showed some effect against other enteroviruses like Polio-1 and Echo-6.

Conclusions:

  • The 5' NCR region (nt 581-601) of CVB3 RNA is critical for viral replication.
  • AODN targeting this region demonstrates significant potential for inhibiting CVB3 replication.
  • AODN represents a promising strategy for developing targeted antiviral therapies against CVB3 and potentially other enteroviruses.

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...